1 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION 
WASHINGTON, D.C. 20549  
FORM 8-K 
CURRENT REPORT  
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  August 18, 2016  
DLH Holdings Corp.  
(Exact name of registrant as specified in its charter)  
 
COMMISSION FILE NUMBER:  0-18492 
New Jersey 22-1899798 
(State or other jurisdiction of incorporation or 
organization) 
(I.R.S. Employer Identification No.) 
 
3565 Piedmont Road, NE, Bldg. 3, Suite 700  
Atlanta, GA 30305 
(Address and zip code of principal executive offices) 
 
(866) 952-1647 
(Registrant's telephone number, including area code) 
 
 
CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED TO SIMULTANEOUSLY 
SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS: 
  
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
  
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
  
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
  
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 2 
Item 1.01 Entry into a Material Definitive Agreement 
 
The Rights Offering 
  
On July 1, 2016, DLH Holdings Corp. (the “Company”) filed a registration statement on Form S-3 with the 
Securities and Exchange Commission (the “Commission”) for a rights offering in which existing 
stockholders of the Company will receive non-transferable rights to purchase up to $2.65 million of 
additional shares of the Company’s common stock (the “Rights Offering”). Under the terms of the Rights 
Offering, the Company will distribute, at no charge to the holders of its common stock as of the record date 
of August 19, 2016, non-transferable subscription rights for each share of common stock owned on the 
record date. Each subscription right will entitle the holder to purchase 0.06827 shares of the Company’s 
common stock at a price of $3.73 per whole share, resulting in the issuance of up to 710,455 shares of 
common stock. The Rights Offering also includes an over-subscription privilege, which entitles a holder 
who exercises its basic subscription privilege in full the right to purchase additional shares of common 
stock that remain unsubscribed at the expiration of the Rights Offering, subject to the availability and pro 
rata allocation of shares among persons exercising this over-subscription right. However, holders will not 
be entitled to purchase a number of shares in the over-subscription privilege in excess of the number of 
shares owned by them as of the record date.  The Company’s Registration Statement on Form S-3 for the 
rights offering was declared effective on August 18, 2016 by the Commission. Mailing of the offering 
materials to eligible stockholders is expected to begin on or about August 22, 2016 and the subscription 
period will expire thirty days following the expected mailing date. 
  
As described in greater detail below, on August 18, 2016, the Company entered into a standby purchase 
agreement with Wynnefield Capital, Inc. (“Wynnefield Capital”), the Company’s largest stockholder, 
whereby Wynnefield Capital (or affiliated assignees) has agreed to acquire from us in the Rights Offering, 
subject to the satisfactions of specified conditions, shares of common stock not otherwise purchased by 
shareholders in the rights offering, up to a maximum amount of $2.5 million of shares. Prior to the Rights 
Offering, Wynnefield Capital, through certain affiliated entities, owns approximately 42% of our 
outstanding common stock. In the event Wynnefield Capital exercised all of the subscription rights offered 
pursuant to the standby purchase agreement, its percentage ownership interest of our common stock would 
increase to approximately 46% of our outstanding shares of common stock. 
  
The Standby Purchase Agreement 
Subject to the terms and conditions of the standby purchase agreement, Wynnefield Capital (or one or more 
affiliated assignees) agreed to purchase from the Company shares of common stock not otherwise 
purchased by shareholders in the Rights Offering pursuant to their basic subscription right and over-
 subscription privilege, up to a maximum amount of $2.5 million of shares. The per share price to be paid by 
Wynnefield Capital (or its assignees) pursuant to the standby purchase agreement will be equal to the 
subscription price for the Rights Offering. The following description of the standby purchase agreement 
with Wynnefield Capital summarizes the material terms of the standby purchase agreement and does not 
purport to be complete and is qualified in its entirety by the full text of the standby purchase agreement, 
which has been filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by 
reference. For purposes of this discussion, we sometimes refer to Wynnefield Capital (and any affiliated 
assignee) as the standby purchaser.  
Conditions to Closing.   The standby purchase agreement provides that the obligations of 
Wynnefield Capital to complete the purchase of our common stock are subject to satisfaction or waiver of 
the conditions specified in the standby purchase agreement, including:  
• The respective representations and warranties of the Company must be true and correct in all 
material respects as of the date of the standby purchase agreement and as of the closing date 
of the offering;
 3 
• Subsequent to the execution and delivery of the standby purchase agreement and prior to the 
closing date, there must not have been any material adverse effect on the Company (as 
defined in the standby purchase agreement);  
 
• As of the closing date, there must not have been a market adverse effect (as defined in the 
standby purchase agreement);  
 
• We must have obtained any required federal, state and regulatory approvals for the Rights 
Offering on conditions reasonably satisfactory to us;  
 
• The prospectus shall contain appropriate disclosure and the rights subscription agreement 
must provide restrictions that no shareholder shall have the right to purchase in the over 
subscription privilege an amount in excess of 100% of the number of shares owned by such 
shareholder on the record date; 
 
• The Company shall have executed a registration rights agreement in form and substance 
satisfactory to Wynnefield Capital providing for the registration for resale under the Securities 
Act of the shares obtained by Wynnefield Capital in connection with the Rights Offering; and  
 
• As of the closing date, the parties have satisfied the usual and customary closing conditions 
set forth in the standby purchase agreement, including delivery to the standby purchaser of an 
opinion of counsel to the Company.  
Under the standby purchase agreement a “material adverse effect” means an event or occurrence 
which has a material adverse effect on the financial condition, or on the earnings, financial position, 
shareholders’ equity, operations, assets, results of operations, regulatory compliance or business of the 
Company and its subsidiaries taken as a whole; provided that the meaning shall exclude any changes from 
general economic, industry, market or competitive conditions or changes in laws, rules or regulations 
generally affecting persons of a similar size in our industry, provided such change does not materially 
disproportionately affect the Company and its subsidiaries taken as a whole compared to others in the 
industry.  
The respective obligations of the Company and Wynnefield Capital to complete the offering to 
standby purchaser are subject to satisfaction or waiver of the following conditions specified in the standby 
purchase agreement:  
• No judgment, injunction, decree, regulatory proceeding or other legal restraint must prohibit, 
or have the effect of rendering unachievable, the consummation of the Rights Offering or the 
sale of stock to the standby purchaser;  
 
• The registration statement shall have become effective and no stop order suspending the 
effectiveness of the registration statement may have been issued and no proceeding for that 
purpose may have been initiated or threatened by the Commission; and  
 
• The shares of common stock to be issued by the Company must have been authorized for 
listing on the Nasdaq Capital Market.  
Terminating the Standby Purchase Agreement.  
        The standby purchase agreement provides that it may be terminated at any time prior to the closing 
date by the standby purchaser by written notice to the Company if there is a material adverse effect or a 
market adverse effect that is not cured within a cure period of 21 days. The standby purchase agreement 
may be terminated by the Company or by the standby purchaser by written notice to the other party:
 4 
• At any time prior to the closing date, if there is a material breach of the agreement by the 
other party that is not cured within 15 days after the non-breaching party has delivered written 
notice to the breaching party of the breach;  
 
• At any time after October 30, 2016, unless the closing has occurred prior to such date; and  
 
• Consummation of the offering to the standby purchaser is prohibited by law, rule or 
regulation. 
 
The standby purchase agreement also provides that it may be terminated by the Company in the 
event it determines that it is not in the best interests of the Company and its shareholders to proceed with 
the Rights Offering.  
Covenants.    
The standby purchase agreement provides that the parties agree to certain covenants which are 
customary for agreements of this nature, including the following: 
 that, until the earlier of the closing date or the effective date of any termination of the standby 
purchase agreement, we will not issue any shares of our capital stock, or options, warrants, 
purchase rights, subscription rights, conversion rights, exchange rights, securities convertible 
into or exchangeable for our capital, or other agreements or rights to purchase or otherwise 
acquire our capital stock, except for (i) shares of common stock issuable upon exercise of 
presently outstanding stock options or other issued and outstanding convertible or derivative 
securities as of the date hereof and (ii) restricted shares of common stock, options to purchase 
shares of common stock, or other awards made in the ordinary course of business and as 
authorized pursuant to our 2016 Omnibus Equity Incentive Plan;  
 
 until the earlier of the closing date or any termination of the standby purchase agreement, the 
standby purchaser and its affiliates shall not acquire any shares of our common stock unless 
authorized by us; 
 
 on the earlier of the closing date and the termination of the standby purchase agreement, other 
than a termination directly and solely attributable to a material breach by the standby 
purchaser, we shall reimburse the standby purchaser for all out-of-pocket fees and expenses 
incurred in connection with the transactions contemplated by the standby purchase agreement, 
not to exceed $50,000; 
 
 we will agree to indemnify and hold harmless the standby purchaser from and against any and 
all losses, claims, damages, liabilities and expenses, which it may incur as a result of or 
arising out of or in any way related to the standby purchase agreement, the proposed offering, 
the use of proceeds or any related transaction or any claim, litigation, investigation or 
proceeding relating to any of the foregoing; provided, however, that the foregoing indemnity 
will not, as to any indemnified person, apply to losses, claims, damages, liabilities or related 
expenses to the extent they have resulted from the bad faith, willful misconduct or gross 
negligence of such indemnified person; and   
 
 we shall solely use the proceeds of the Rights Offering in accordance with the description set 
forth in the prospectus included in the registration statement for the Rights Offering. 
 
We have also agreed to enter into a registration rights agreement with Wynnefield Capital whereby we will, 
at our cost and expense, register for resale under the Securities Act of 1933, all of the shares of common 
stock purchased by Wynnefield Capital in the Rights Offering and which may be acquired by Wynnefield
 5 
Capital upon exercise of certain warrants that it holds. We will agree to file a registration statement with the 
Commission within 90 days of closing of the Rights Offering. The Company and Wynnefield Capital 
intend to execute the registration rights agreement upon the expiration of the Rights Offering. A copy of the 
form of registration rights agreement was filed as Exhibit 10.3 to the Company’s pre-effective amendment 
to the registration statement on Form S-3 filed with the Commission on August 10, 2016 and is 
incorporated herein by reference. 
 
This Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities 
described herein, nor shall there be any offer or sale of such securities in any jurisdiction in which such 
offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of 
any such jurisdiction. A registration statement relating to these securities has been filed with the Securities 
and Exchange Commission and was declared effective on August 18, 2016. The offering will be made only 
by means of a prospectus which is a part of such registration statement. Copies of the prospectus for the 
Rights Offering may be obtained by contacting the Company’s information agent, Continental Stock 
Transfer & Trust Company, at (917) 262-2378. 
 
Item 9.01 Financial Statements and Exhibits 
  
(d) 
Exhibit  
Number 
 
Exhibit Title or Description  
 10.1 Standby Purchase Agreement
 6 
SIGNATURE 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused 
this report to be signed on its behalf by the undersigned, hereunto duly authorized. 
    DLH Holdings Corp. 
      
    By:  /s/ Kathryn M. JohnBull 
     
    Name: Kathryn M. JohnBull 
    Title:   Chief Financial Officer  
 Date:   August 19, 2016
 7 
EXHIBIT INDEX 
Exhibit 
Number   Description                                                                                                       
  
10.1 Standby Purchase Agreement